作者：
Youri,Lee [1]
;
Gabrielle,Grubbs [1]
;
Sabrina C,Ramelli [2]
;
Andrea R,Levine [3]
;
Allison,Bathula [4]
;
Kapil,Saharia [5]
;
Madeleine,Purcell [6]
;
Shreya,Singireddy [6]
;
Colleen L,Dugan [7]
;
Lindsey,Kirchoff [7]
;
Allison,Lankford [8]
;
Sarah,Cipriano [7]
;
Ryan A,Curto [6]
;
Jocelyn,Wu [6]
;
Katherine,Raja [6]
;
Emily,Kelley [7]
;
Daniel,Herr [9]
;
Kevin M,Vannella [10]
;
Supriya,Ravichandran [1]
;
Juanjie,Tang [1]
;
Anthony,Harris [11]
;
Mohammad,Sajadi [12]
;
Daniel S,Chertow [10]
;
Alison,Grazioli [13]
;
Surender,Khurana [14]
作者单位：
Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), 10903 New Hampshire Avenue, Silver Spring, MD 20871, USA.
[1]
Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA.
[2]
Division of Pulmonary and Critical Care, Department of Internal Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
[3]
Department of Pharmacy, University of Maryland Medical Center, Baltimore, MD, USA.
[4]
Division of Infectious Disease, Department of Internal Medicine, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD USA.
[5]
University of Maryland School of Medicine, Baltimore, MD USA.
[6]
University of Maryland Medical Center, Baltimore, MD USA.
[7]
Department of Obstetrics and Gynecology, University of Maryland School of Medicine, Baltimore, MD, USA.
[8]
Department of Medicine, Program in Trauma, University of Maryland School of Medicine, Baltimore, MD, USA.
[9]
Emerging Pathogens Section, Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
[10]
Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD USA.
[11]
Department of Medicine, Baltimore VA Medical Center, Baltimore, MD 21201, USA.
[12]
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD USA.
[13]
Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), 10903 New Hampshire Avenue, Silver Spring, MD 20871, USA. Electronic address: Surender.Khurana@fda.hhs.gov.
[14]
DOI
10.1016/j.ebiom.2022.103940
PMID
35301181
发布时间
2023-12-13
换一批
换一批
